[1]CurrentPatentAssignee:ALCON,INC.-US2005/288283,2005,A1Locationinpatent:Page/Pagecolumn3
[1]CurrentPatentAssignee:ALCON,INC.-US2005/288283,2005,A1Locationinpatent:Page/Pagecolumn3
[1]CurrentPatentAssignee:UNIVERSITYOFZURICH-US2007/232814,2007,A1Locationinpatent:Page/Pagecolumn25;26
[2]CurrentPatentAssignee:UNIVERSITYOFZURICH-US2007/232814,2007,A1Locationinpatent:Page/Pagecolumn30
[3]CurrentPatentAssignee:HOLDINGF.I.S.S.P.A.-WO2010/121877,2010,A2Locationinpatent:Page/Pagecolumn27-28
[4]CurrentPatentAssignee:URIACHS.A.-WO2006/10459,2006,A1Locationinpatent:Page/Pagecolumn15
[5]CurrentPatentAssignee:URIACHS.A.-EP1908758,2008,A1Locationinpatent:Page/Pagecolumn6
Title: Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis.
Journal: Experimental dermatology 20120901
Title: [A 10-week safety and efficacy evaluation of olopatadine, 0.2% instilled twice-daily in patients with allergic conjunctivitis in Japan].
Journal: Nippon Ganka Gakkai zasshi 20120901
Title: The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice.
Journal: Allergy 20120801
Title: Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer.
Journal: The Journal of organic chemistry 20120720
Title: Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
Journal: Clinical therapeutics 20120601
Title: Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
Journal: Archives of dermatological research 20120501
Title: The effect of antihistamines on seizures induced by increasing-current electroshocks: ketotifen, but not olopatadine, promotes the seizures in infant rats.
Journal: Biological & pharmaceutical bulletin 20120101
Title: Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.
Journal: Expert opinion on drug metabolism & toxicology 20111201
Title: Thermal angiooedema induced by hot water.
Journal: Acta dermato-venereologica 20110501
Title: Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis.
Journal: American journal of ophthalmology 20110401
Title: A rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of olopatadine concentration in human plasma.
Journal: Journal of analytical toxicology 20110301
Title: Intrastromal corneal ring segments for bilateral keratoconus in an 11-year-old boy.
Journal: Journal of cataract and refractive surgery 20110101
Title: Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.
Journal: Drug design, development and therapy 20110101
Title: Olopatadine hydrochloride inhibits capsaicin-induced flare response in humans.
Journal: Pharmacology 20110101
Title: Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
Journal: Allergy and asthma proceedings 20110101
Title: Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.
Journal: Allergy and asthma proceedings 20110101
Title: Olopatadine 0.6% nasal spray protects from vasomotor challenge in patients with severe vasomotor rhinitis.
Journal: American journal of rhinology & allergy 20110101
Title: Olopatadine suppresses the late phase reaction in parthenium dermatitis.
Journal: Indian journal of dermatology, venereology and leprology 20110101
Title: Stability-indicating high-performance column liquid chromatography and high-performance thin-layer chromatography methods for the determination of olopatadine hydrochloride in tablet dosage form.
Journal: Journal of AOAC International 20110101
Title: Dermatitis induced by estrogen and progesterone: dual positive results on the intradermal skin test.
Journal: Dermatitis : contact, atopic, occupational, drug 20110101
Title: Olopatadine hydrochloride in children: efficacy and safety for perennial allergic rhinitis.
Journal: Current medical research and opinion 20100701
Title: Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.
Journal: Eye & contact lens 20100701
Title: Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
Journal: Expert opinion on pharmacotherapy 20100601
Title: Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
Journal: Expert opinion on pharmacotherapy 20100401
Title: Olopatadine nasal spray for the treatment of allergic rhinitis.
Journal: Expert review of clinical immunology 20100301
Title: Histamine stimulates interleukin-6 production through histamine H1 receptors in human amnion cells.
Journal: Gynecologic and obstetric investigation 20100101
Title: Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis.
Journal: Allergy and asthma proceedings 20100101
Title: Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
Journal: European journal of ophthalmology 20100101
Title: [Toxicity of topical ocular anti-allergic agents on human corneal epithelial cells in vitro].
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20100101
Title: Comprehensive review of olopatadine: the molecule and its clinical entities.
Journal: Allergy and asthma proceedings 20100101
Title: Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice.
Journal: International archives of allergy and immunology 20100101
Title: Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Journal: Pharmacology 20100101
Title: Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Journal: Allergy and asthma proceedings 20100101
Title: Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells.
Journal: The Journal of dermatology 20091201
Title: Olopatadine hydrochloride inhibits scratching behavior induced by a proteinase-activated receptor 2 agonist in mice.
Journal: Journal of dermatological science 20091101
Title: Azelastine and olopatadine in the treatment of allergic rhinitis.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20091101
Title: Multiple action agents and the eye: do they really stabilize mast cells?
Journal: Current opinion in allergy and clinical immunology 20091001
Title: Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Journal: Acta ophthalmologica 20090801
Title: Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20090601
Title: Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride.
Journal: The Journal of dermatology 20090401
Title: Drug approvals: '08 in review. Olopatadine hydrochloride (Patanase) nasal spray.
Journal: The Nurse practitioner 20090201
Title: Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Journal: Journal of dermatological science 20090101
Title: Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Journal: Clinical therapeutics 20090101
Title: Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis?
Journal: Allergy and asthma proceedings 20090101
Title: Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.
Journal: Clinical drug investigation 20090101
Title: Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
Journal: Allergy and asthma proceedings 20090101
Title: Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.
Journal: BMC ophthalmology 20090101
Title: Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
Journal: Journal of investigational allergology & clinical immunology 20090101
Title: Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Journal: Pharmacology 20090101
Title: Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
Journal: Allergy and asthma proceedings 20090101
Title: [Effectiveness of olopatadine therapy in seasonal allergic conjunctivitis].
Journal: Oftalmologia (Bucharest, Romania : 1990) 20090101
Title: [Comparison of olopatadin and ketotifen in the treatment of allergic conjunctivitis].
Journal: Revista medica del Instituto Mexicano del Seguro Social 20090101
Title: Comparison of the conjunctival toxicity of topical ocular antiallergic agents.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201
Title: Repeated pre-treatment with antihistamines suppresses [corrected] transcriptional up-regulations of histamine H(1) receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats.
Journal: Journal of pharmacological sciences 20081201
Title: Effects of olopatadine in limited scleroderma with peripheral eosinophils.
Journal: Geriatrics & gerontology international 20080901
Title: Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Journal: Archives of dermatological research 20080701
Title: The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080701
Title: Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Journal: International immunopharmacology 20080601
Title: Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
Journal: Experimental eye research 20080501
Title: Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
Journal: Expert opinion on drug metabolism & toxicology 20080401
Title: Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Journal: Methods and findings in experimental and clinical pharmacology 20080401
Title: Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
Journal: Current medical research and opinion 20080201
Title: Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function.
Journal: Pharmacology 20080101
Title: The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.
Journal: Pharmacology 20080101
Title: P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist.
Journal: Drug metabolism and pharmacokinetics 20080101
Title: Enhancement of basophil apoptosis by olopatadine and theophylline.
Journal: Allergy and asthma proceedings 20080101
Title: A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis.
Journal: Allergy and asthma proceedings 20080101
Title: Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
Journal: Allergy and asthma proceedings 20080101
Title: Use of olopatadine ophthalmic solution and reactivity of histamine skin testing.
Journal: Allergy and asthma proceedings 20080101
Title: An assessment of the onset and duration of action of olopatadine nasal spray.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20071201
Title: Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.
Journal: Current eye research 20071201
Title: Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20071101
Title: [Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070901
Title: Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801
Title: Safety and tolerability of olopatadine 0.2% in children and adolescents.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801
Title: The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells.
Journal: Allergology international : official journal of the Japanese Society of Allergology 20070601
Title: Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
Journal: Current medical research and opinion 20070601
Title: Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.
Journal: The British journal of dermatology 20070501
Title: Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070201
Title: Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines.
Journal: Journal of investigational allergology & clinical immunology 20070101
Title: Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
Journal: Allergy and asthma proceedings 20070101
Title: Chronic red eyes. Diagnosis: allergic conjunctivitis due to airborne allergen.
Journal: Comprehensive ophthalmology update 20070101
Title: Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
Journal: Allergy and asthma proceedings 20070101
Title: Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis.
Journal: Advances in therapy 20070101
Title: Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
Journal: Allergy and asthma proceedings 20070101
Title: Olopatadine attenuates the enhancement of capsaicin-evoked substance P release by bradykinin from cultured dorsal root ganglion neurons.
Journal: European journal of pharmacology 20061215
Title: Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
Journal: Eye & contact lens 20061201
Title: Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
Journal: European journal of pharmacology 20061010
Title: [Clinical effects of olopatadine hydrochloride on pruritus in skin diseases].
Journal: Arerugi = [Allergy] 20061001
Title: Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.
Journal: Clinical therapeutics 20061001
Title: [The use of 'Antigrippin-maximum' in the complex therapy of patients with acute respiratory diseases].
Journal: Voenno-meditsinskii zhurnal 20061001
Title: [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis].
Journal: Orvosi hetilap 20060910
Title: Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK.
Journal: Current medical research and opinion 20060901
Title: Allergic tears promote upregulation of eosinophil adhesion to conjunctival epithelial cells in an ex vivo model: inhibition with olopatadine treatment.
Journal: Investigative ophthalmology & visual science 20060801
Title: [Misleading advertisement on Opatanol].
Journal: Nederlands tijdschrift voor geneeskunde 20060701
Title: Pharmacotherapy of allergic eye disease.
Journal: Expert opinion on pharmacotherapy 20060601
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Red, itchy eyes, giant papillae.
Journal: Advance for nurse practitioners 20060301
Title: Role of substance P in allergic nasal symptoms in rats.
Journal: European journal of pharmacology 20060217
Title: Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
Journal: Acta ophthalmologica Scandinavica 20060201
Title: Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
Journal: British journal of clinical pharmacology 20060101
Title: Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.
Journal: Mediators of inflammation 20060101
Title: Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
Journal: Allergy and asthma proceedings 20060101
Title: [Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].
Journal: Arquivos brasileiros de oftalmologia 20060101
Title: Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice.
Journal: Pharmacology 20051201
Title: Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20051201
Title: The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
Journal: European journal of pharmacology 20051107
Title: Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20051101
Title: Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20051001
Title: Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20051001
Title: The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis.
Journal: The Journal of dermatology 20051001
Title: Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.
Journal: Current medical research and opinion 20050901
Title: Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Journal: Clinical therapeutics 20050901
Title: Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
Journal: Current medical research and opinion 20050501
Title: A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
Journal: Clinical therapeutics 20050501
Title: Effect of ketotifen fumarate, olopatadine, and levocabastine on ocular active anaphylaxis in the guinea pig and ocular immediate hypersensitivity in the albino rat.
Journal: Ocular immunology and inflammation 20050201
Title: [Examination of effectiveness of olopatadine hydrochloride in atopic dermatitis].
Journal: Arerugi = [Allergy] 20050201
Title: Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050101
Title: Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: suppressive effects on skin response to histamine iontophoresis.
Journal: The Journal of dermatology 20050101
Title: Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Journal: Journal of dermatological science 20041201
Title: Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.
Journal: The British journal of dermatology 20041201
Title: Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Journal: Current medical research and opinion 20041201
Title: A review of olopatadine for the treatment of ocular allergy.
Journal: Expert opinion on pharmacotherapy 20040901
Title: Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Journal: Clinical and experimental dermatology 20040901
Title: Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
Journal: Current medical research and opinion 20040801
Title: Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.
Journal: Current medical research and opinion 20040801
Title: Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.
Journal: Clinical therapeutics 20040801
Title: Ocular allergy treatment comparisons: azelastine and olopatadine.
Journal: Current allergy and asthma reports 20040701
Title: A review of the use of olopatadine in allergic conjunctivitis.
Journal: International ophthalmology 20040501
Title: Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells.
Journal: Biochemical pharmacology 20040401
Title: [Olopatadine].
Journal: Revue de l'infirmiere 20040401
Title: The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20040101
Title: Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.
Journal: Allergy and asthma proceedings 20040101
Title: Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
Journal: Arzneimittel-Forschung 20040101
Title: Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
Journal: Human psychopharmacology 20031201
Title: Interactions of olopatadine and selected antihistamines with model and natural membranes.
Journal: Ocular immunology and inflammation 20031201
Title: Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans.
Journal: Clinical therapeutics 20031001
Title: Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
Journal: Acta ophthalmologica Scandinavica 20030801
Title: Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Journal: Clinical therapeutics 20030801
Title: [Opatanol].
Journal: Ugeskrift for laeger 20030721
Title: One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears.
Journal: Clinical therapeutics 20030701
Title: Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Journal: Cellular immunology 20030701
Title: Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
Journal: Eye & contact lens 20030401
Title: [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Journal: Journal francais d'ophtalmologie 20030401
Title: Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
Journal: International archives of allergy and immunology 20030301
Title: A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
Journal: Clinical therapeutics 20030301
Title: Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort.
Journal: Advances in therapy 20030101
Title: Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20021201
Title: A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.
Journal: Clinical therapeutics 20021001
Title: Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge model.
Journal: Clinical therapeutics 20020901
Title: Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study.
Journal: Clinical therapeutics 20020801
Title: Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
Journal: Clinical therapeutics 20020701
Title: Occupational allergy caused by Peruvian lily (Alstroemeria).
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020601
Title: Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model.
Journal: Clinical therapeutics 20020601
Title: Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20020501
Title: Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein.
Journal: Biochemical and biophysical research communications 20020412
Title: Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
Journal: Japanese journal of pharmacology 20020401
Title: Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.
Journal: Japanese journal of pharmacology 20020401
Title: Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine.
Journal: Allergy and asthma proceedings 20020101
Title: Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20011101
Title: Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly-L-arginine in rats.
Journal: Japanese journal of pharmacology 20011001
Title: Mucus fishing syndrome: case report and new treatment option.
Journal: Optometry (St. Louis, Mo.) 20011001
Title: Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.
Journal: Clinical therapeutics 20010801
Title: [Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride' (olopatadine), an antiallergic drug].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010701
Title: Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20010601
Title: [Effect of olopatadine hydrochloride, a novel antiallergic agent, on the QT interval in dogs].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010601
Title: Inhibitory effect of olopatadine hydrochloride on the sneezing response induced by intranasal capsaicin challenge in guinea pigs.
Journal: Japanese journal of pharmacology 20010601
Title: Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs.
Journal: Japanese journal of pharmacology 20010401
Title: Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 19971201
Title: The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 19960101
Title: Tamura, T., et al., Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice. Pharmacology, 2005. 75(1): p. 45-52.
Title: Ohmori, K., et al., Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn J Pharmacol, 2002. 88(4): p. 379-97.
Title: Yanni, J.M., et al., The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther, 1996. 12(4): p. 389-400.
